InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · IEX Real-Time Price · USD

0.248

-0.004 (-1.51%)

At close: Jul 2, 2024, 3:45 PM

0.254

+0.006 (2.34%)

After-hours: Jul 2, 2024, 7:09 PM EDT

InMed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020
Market Capitalization	2	3	7	26	-
Market Cap Growth	-38.66%	-55.23%	-73.10%	-	-
Enterprise Value	-5	-5	1	18	-6
PE Ratio	-	-0.39	-0.37	-2.51	-
PS Ratio	0.37	0.75	6.32	-	-
PB Ratio	0.19	0.26	0.76	3.47	-
P/FCF Ratio	-0.33	-0.41	-0.44	-2.61	-
P/OCF Ratio	-0.33	-0.42	-0.44	-2.61	-
EV/Sales Ratio	-0.91	-1.33	0.98	-	-
EV/EBITDA Ratio	0.93	0.75	-0.06	-1.92	0.63
EV/EBIT Ratio	0.84	0.69	-0.06	-1.88	0.62
EV/FCF Ratio	0.77	0.74	-0.07	-1.89	0.75
Debt / Equity Ratio	0.03	0.03	0.04	0.04	0.05
Debt / EBITDA Ratio	-0.06	-0.05	-0.02	-0.03	-0.04
Debt / FCF Ratio	-0.05	-0.05	-0.03	-0.03	-0.04
Quick Ratio	5.14	4.61	1.90	3.35	3.52
Current Ratio	6.58	5.66	2.89	3.78	3.77
Asset Turnover	0.42	0.27	0.07	0	0
Interest Coverage	-	-	-	-27.31	-
Return on Equity (ROE)	-53.40%	-63.80%	-150.70%	-136.60%	-88.90%
Return on Assets (ROA)	-45.30%	-52.70%	-114.50%	-100.80%	-76.90%
Return on Capital (ROIC)	-58.00%	-67.22%	-182.06%	-129.97%	-147.71%
Earnings Yield	-293.38%	-257.74%	-270.06%	-39.85%	-
FCF Yield	-321.45%	-241.44%	-226.83%	-38.25%	-
Buyback Yield / Dilution	-188.83%	-336.58%	-108.65%	-28.72%	-0.55%
Total Shareholder Return	-188.83%	-336.58%	-108.65%	-28.72%	-0.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).